[go: up one dir, main page]

ES2175153T3 - Uso de inhibidores de colinesterasa para la fabricacion de un medicamento para el tratamiento de la xerostomia. - Google Patents

Uso de inhibidores de colinesterasa para la fabricacion de un medicamento para el tratamiento de la xerostomia.

Info

Publication number
ES2175153T3
ES2175153T3 ES96940220T ES96940220T ES2175153T3 ES 2175153 T3 ES2175153 T3 ES 2175153T3 ES 96940220 T ES96940220 T ES 96940220T ES 96940220 T ES96940220 T ES 96940220T ES 2175153 T3 ES2175153 T3 ES 2175153T3
Authority
ES
Spain
Prior art keywords
xerostomy
manufacture
treatment
medicinal product
cholinesterase inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96940220T
Other languages
English (en)
Inventor
Jorgen Ekstrom
Herbert Helander
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biora AB
Original Assignee
Biora AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biora AB filed Critical Biora AB
Application granted granted Critical
Publication of ES2175153T3 publication Critical patent/ES2175153T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

SE DESCRIBE EL USO DE UN INHIBIDOR DE LA COLINESTERASA EN LA FABRICACION DE UN MEDICAMENTO PARA LA ADMINISTRACION POR VIA TOPICA, PARA SU UTILIZACION EN EL TRATAMIENTO DE LA XEROSTOMIA.
ES96940220T 1995-11-29 1996-11-25 Uso de inhibidores de colinesterasa para la fabricacion de un medicamento para el tratamiento de la xerostomia. Expired - Lifetime ES2175153T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9504267A SE9504267D0 (sv) 1995-11-29 1995-11-29 New therapeutic use

Publications (1)

Publication Number Publication Date
ES2175153T3 true ES2175153T3 (es) 2002-11-16

Family

ID=20400405

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96940220T Expired - Lifetime ES2175153T3 (es) 1995-11-29 1996-11-25 Uso de inhibidores de colinesterasa para la fabricacion de un medicamento para el tratamiento de la xerostomia.

Country Status (14)

Country Link
US (1) US5962503A (es)
EP (1) EP0866699B1 (es)
JP (1) JP4113257B2 (es)
CN (2) CN101380320B (es)
AR (1) AR004330A1 (es)
AT (1) ATE216235T1 (es)
AU (1) AU718661B2 (es)
DE (1) DE69620786T2 (es)
DK (1) DK0866699T3 (es)
ES (1) ES2175153T3 (es)
PT (1) PT866699E (es)
SE (1) SE9504267D0 (es)
WO (1) WO1997019685A1 (es)
ZA (1) ZA969586B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1401481A1 (en) * 2001-06-14 2004-03-31 Novo Nordisk A/S Mucosal repair by tff dimer peptides
JP2006070027A (ja) * 2004-08-06 2006-03-16 Dai Ichi Seiyaku Co Ltd 口腔粘膜投与剤
US20060263414A1 (en) * 2005-05-19 2006-11-23 Pauline Pan Confectionery products for the treatment of dry mouth
US20070077300A1 (en) * 2005-09-30 2007-04-05 Wynn David W Oral compositions containing a salivation inducing agent
US20090053309A1 (en) * 2007-08-24 2009-02-26 Axiomedic Ltd., Gibraltar Adhesive compositions for the treatment of xerostomia
US9161909B2 (en) * 2007-08-24 2015-10-20 Axiomedic Ltd. Adhesive compositions for the treatment of xerostomia
CN114010575B (zh) * 2021-10-22 2024-06-28 江苏谛奇医药科技有限公司 新斯的明及其衍生物的新制剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5187165A (en) * 1987-05-15 1993-02-16 Hoechst-Roussel Pharmaceuticals Inc. Memory enhancing and analgesic 1,2,3a,8,8a-hexahydro-3a,8(and 1,3a,8)-di(and tri)methylpyrrolo[2,3-b]indoles
SE9103752D0 (sv) * 1991-12-18 1991-12-18 Astra Ab New compounds
US5387614A (en) * 1993-07-27 1995-02-07 University Of Iowa Research Foundation Use of sigma receptor ligands as salivary gland stimulants

Also Published As

Publication number Publication date
AU718661B2 (en) 2000-04-20
ZA969586B (en) 1997-05-29
CN101380320B (zh) 2010-12-29
WO1997019685A1 (en) 1997-06-05
CN1207679A (zh) 1999-02-10
CN101380320A (zh) 2009-03-11
EP0866699B1 (en) 2002-04-17
JP4113257B2 (ja) 2008-07-09
DK0866699T3 (da) 2002-08-12
US5962503A (en) 1999-10-05
AR004330A1 (es) 1998-11-04
PT866699E (pt) 2002-08-30
AU7716096A (en) 1997-06-19
JP2000508618A (ja) 2000-07-11
ATE216235T1 (de) 2002-05-15
EP0866699A1 (en) 1998-09-30
DE69620786D1 (de) 2002-05-23
SE9504267D0 (sv) 1995-11-29
DE69620786T2 (de) 2002-11-21

Similar Documents

Publication Publication Date Title
SE9504661D0 (sv) New compounds
EE200000320A (et) Uudsed ühendid
SE9704544D0 (sv) Novel compounds
MX9602683A (es) Compuestos de 6-dimetilaminometil-1-fenil-ciclohexano como substancias farmaceuticamente activas.
TR199801151T2 (xx) Trombin inhibit�r� �n ila�lar.
AR004700A1 (es) 1alfa, 26 dihidroxi-d-homo-vitamina d3, una composicion farmaceutica que la comprende, un procedimiento para su preparacion y el uso de los mismos en laelaboracion de un medicamento
UY26372A1 (es) "imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen "
ATE252885T1 (de) Plan zur verabreichung von h+, k+-atpase inhibitoren
IT1285770B1 (it) Composti corticoidei
AU8736798A (en) Use of cholinesterase inhibitors for treating attention deficit disorders
ATE308328T1 (de) Pharmazeutische zusammensetzung enthaltend clindamycin und clotrimazol, zur behandlung vaginaler infektionen
SE9601556D0 (sv) New pharmaceutical formulation of a thrombin inhibitor for parenteral use
ES2175153T3 (es) Uso de inhibidores de colinesterasa para la fabricacion de un medicamento para el tratamiento de la xerostomia.
PT1150704E (pt) Melagatran para o tratamento da inflamacao
ATE360428T1 (de) Analgetisches arzneimittel
AU7270798A (en) Antithrombotic agents
SE9504662D0 (sv) New compounds
FI963567A0 (fi) Diklofenakki-Na:a sisältävä depottabletti
AR059965A2 (es) Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante
IT1317049B1 (it) Composti utili per la preparazione di medicamenti ad attivita'inibitrice della fosfodiesterasi iv.
AU7470098A (en) Antithrombotic agents
ES2065855B1 (es) Procedimiento para la preparacion de nuevos derivados desoxiazafosfolipidicos con accion inhibidora de la fosfolipasa a2, nuevos derivados desoxiazafosfolipidicos obtenidos y utilizacion de los mismos.
DE59510583D1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
ES2049711T1 (es) Uso de bucilamina para la fabricacion de un medicamento para el tratamiento de la cistinuria.
ES2165970T3 (es) Forma farmaceutica solida con principio activo distribuido en un material polimerico.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 866699

Country of ref document: ES